{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:48:16Z","timestamp":1776710896884,"version":"3.51.2"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cell-to-cell propagation of aggregated alpha synuclein (aSyn) has been suggested to play an important role in the progression of alpha synucleinopathies. A critical step for the propagation process is the accumulation of extracellular aSyn within recipient cells. Here, we investigated the trafficking of distinct exogenous aSyn forms and addressed the mechanisms influencing their accumulation in recipient cells. The aggregated aSyn species (oligomers and fibrils) exhibited more pronounced accumulation within recipient cells than aSyn monomers. In particular, internalized extracellular aSyn in the aggregated forms was able to seed the aggregation of endogenous aSyn. Following uptake, aSyn was detected along endosome-to-lysosome and autophagosome-to-lysosome routes. Intriguingly, aggregated aSyn resulted in lysosomal activity impairment, accompanied by the accumulation of dilated lysosomes. Moreover, analysis of autophagy-related protein markers suggested decreased autophagosome clearance. In contrast, the endocytic pathway, proteasome activity, and mitochondrial homeostasis were not substantially affected in recipient cells. Our data suggests that extracellularly added aggregated aSyn primarily impairs lysosomal activity, consequently leading to aSyn accumulation within recipient cells. Importantly, the autophagy inducer trehalose prevented lysosomal alterations and attenuated aSyn accumulation within aSyn-exposed cells. Our study underscores the importance of lysosomes for the propagation of aSyn pathology, thereby proposing these organelles as interventional targets.<\/jats:p>","DOI":"10.1038\/s41598-018-35811-8","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T11:05:12Z","timestamp":1548327912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose"],"prefix":"10.1038","volume":"9","author":[{"given":"Anna-Carin","family":"Hoffmann","sequence":"first","affiliation":[]},{"given":"Georgia","family":"Minakaki","sequence":"additional","affiliation":[]},{"given":"Stefanie","family":"Menges","sequence":"additional","affiliation":[]},{"given":"Rachele","family":"Salvi","sequence":"additional","affiliation":[]},{"given":"Sergey","family":"Savitskiy","sequence":"additional","affiliation":[]},{"given":"Aida","family":"Kazman","sequence":"additional","affiliation":[]},{"given":"Hugo","family":"Vicente Miranda","sequence":"additional","affiliation":[]},{"given":"Dirk","family":"Mielenz","sequence":"additional","affiliation":[]},{"given":"Jochen","family":"Klucken","sequence":"additional","affiliation":[]},{"given":"J\u00fcrgen","family":"Winkler","sequence":"additional","affiliation":[]},{"given":"Wei","family":"Xiang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"35811_CR1","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba, M. et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152, 879\u2013884 (1998).","journal-title":"Am J Pathol"},{"key":"35811_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"35811_CR3","first-page":"1169","volume":"78","author":"A Takeda","year":"1998","unstructured":"Takeda, A. et al. Abnormal distribution of the non-Abeta component of Alzheimer\u2019s disease amyloid precursor\/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Invest 78, 1169\u20131177 (1998).","journal-title":"Lab Invest"},{"key":"35811_CR4","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1073\/pnas.0712179105","volume":"105","author":"M Vilar","year":"2008","unstructured":"Vilar, M. et al. The fold of alpha-synuclein fibrils. Proc Natl Acad Sci USA 105, 8637\u20138642 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35811_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-1326-4-24","volume":"4","author":"KA Malkus","year":"2009","unstructured":"Malkus, K. A., Tsika, E. & Ischiropoulos, H. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson\u2019s disease: how neurons are lost in the Bermuda triangle. Mol Neurodegener 4, 24 (2009).","journal-title":"Mol Neurodegener"},{"key":"35811_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4161\/auto.19371","volume":"8","author":"J Klucken","year":"2012","unstructured":"Klucken, J. et al. Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway. Autophagy 8, 754\u2013766 (2012).","journal-title":"Autophagy"},{"key":"35811_CR7","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.4161\/auto.36436","volume":"10","author":"AM Poehler","year":"2014","unstructured":"Poehler, A. M. et al. Autophagy modulates SNCA\/alpha-synuclein release, thereby generating a hostile microenvironment. Autophagy 10, 2171\u20132192 (2014).","journal-title":"Autophagy"},{"key":"35811_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","volume":"287","author":"R Borghi","year":"2000","unstructured":"Borghi, R. et al. Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson\u2019s disease and normal subjects. Neurosci Lett 287, 65\u201367 (2000).","journal-title":"Neurosci Lett"},{"key":"35811_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf, O. M. et al. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. Faseb J 20, 419\u2013425 (2006).","journal-title":"Faseb J"},{"key":"35811_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol Aging"},{"key":"35811_CR11","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1002\/mds.22369","volume":"23","author":"JH Kordower","year":"2008","unstructured":"Kordower, J. H., Chu, Y., Hauser, R. A., Olanow, C. W. & Freeman, T. B. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 23, 2303\u20132306 (2008).","journal-title":"Mov Disord"},{"key":"35811_CR12","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1073\/pnas.1605245113","volume":"113","author":"W Li","year":"2016","unstructured":"Li, W. et al. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc Natl Acad Sci USA 113, 6544\u20136549 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35811_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc 9, 2135\u20132146 (2014).","journal-title":"Nat Protoc"},{"key":"35811_CR14","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 209, 975\u2013986 (2012).","journal-title":"J Exp Med"},{"key":"35811_CR15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","volume":"288","author":"CH Westphal","year":"2013","unstructured":"Westphal, C. H. & Chandra, S. S. Monomeric synucleins generate membrane curvature. J Biol Chem 288, 1829\u20131840 (2013).","journal-title":"J Biol Chem"},{"key":"35811_CR16","doi-asserted-by":"publisher","first-page":"e0168700","DOI":"10.1371\/journal.pone.0168700","volume":"11","author":"J Domert","year":"2016","unstructured":"Domert, J. et al. Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes. PLoS One 11, e0168700 (2016).","journal-title":"PLoS One"},{"key":"35811_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1326-7-38","volume":"7","author":"M Konno","year":"2012","unstructured":"Konno, M. et al. Suppression of dynamin GTPase decreases alpha-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol Neurodegener 7, 38 (2012).","journal-title":"Mol Neurodegener"},{"key":"35811_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08720-5","volume":"7","author":"E Ihse","year":"2017","unstructured":"Ihse, E. et al. Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type. Sci Rep 7, 9008 (2017).","journal-title":"Sci Rep"},{"key":"35811_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mcn.2013.01.004","volume":"54","author":"W Xiang","year":"2013","unstructured":"Xiang, W. et al. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity. Mol Cell Neurosci 54, 71\u201383 (2013).","journal-title":"Mol Cell Neurosci"},{"key":"35811_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-9-39","volume":"9","author":"TE Hansen","year":"2011","unstructured":"Hansen, T. E. & Johansen, T. Following autophagy step by step. BMC Biol 9, 39 (2011).","journal-title":"BMC Biol"},{"key":"35811_CR21","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3390\/ph5111177","volume":"5","author":"A Erazo-Oliveras","year":"2012","unstructured":"Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T. Y. & Pellois, J. P. Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals (Basel) 5, 1177\u20131209 (2012).","journal-title":"Pharmaceuticals (Basel)"},{"key":"35811_CR22","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.celrep.2015.12.075","volume":"14","author":"SH Oh","year":"2016","unstructured":"Oh, S. H. et al. Mesenchymal Stem Cells Inhibit Transmission of alpha-Synuclein by Modulating Clathrin-Mediated Endocytosis in a Parkinsonian Model. Cell Rep 14, 835\u2013849 (2016).","journal-title":"Cell Rep"},{"key":"35811_CR23","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","volume":"40","author":"HJ Lee","year":"2008","unstructured":"Lee, H. J. et al. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Biol 40, 1835\u20131849 (2008).","journal-title":"Int J Biochem Cell Biol"},{"key":"35811_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-017-0445-5","volume":"5","author":"J Ngolab","year":"2017","unstructured":"Ngolab, J. et al. Brain-derived exosomes from dementia with Lewy bodies propagate alpha-synuclein pathology. Acta Neuropathol Commun 5, 46 (2017).","journal-title":"Acta Neuropathol Commun"},{"key":"35811_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00232-014-9637-0","volume":"247","author":"S Tortorella","year":"2014","unstructured":"Tortorella, S. & Karagiannis, T. C. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy. J Membr Biol 247, 291\u2013307 (2014).","journal-title":"J Membr Biol"},{"key":"35811_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4161\/auto.5338","volume":"4","author":"DJ Klionsky","year":"2008","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151\u2013175 (2008).","journal-title":"Autophagy"},{"key":"35811_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4161\/auto.4600","volume":"3","author":"N Mizushima","year":"2007","unstructured":"Mizushima, N. & Yoshimori, T. How to interpret LC3 immunoblotting. Autophagy 3, 542\u2013545 (2007).","journal-title":"Autophagy"},{"key":"35811_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.117","volume":"47","author":"A Ciechanover","year":"2015","unstructured":"Ciechanover, A. & Kwon, Y. T. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 47, e147 (2015).","journal-title":"Exp Mol Med"},{"key":"35811_CR29","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A. & Rubinsztein, D. C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 282, 5641\u20135652 (2007).","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"35811_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir, S. The clinical symptoms of Parkinson\u2019s disease. J Neurochem 139(Suppl 1), 318\u2013324 (2016).","journal-title":"J Neurochem"},{"issue":"Suppl","key":"35811_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1679\/aohc.52.Suppl_191","volume":"52","author":"K Wakabayashi","year":"1989","unstructured":"Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E. & Ikuta, F. Lewy bodies in the enteric nervous system in Parkinson\u2019s disease. Arch Histol Cytol 52(Suppl), 191\u2013194 (1989).","journal-title":"Arch Histol Cytol"},{"key":"35811_CR32","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner, B. et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci USA 108, 4194\u20134199 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35811_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8314","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer, U. et al. Parkinson-causing alpha-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun 6, 7314 (2015).","journal-title":"Nat Commun"},{"key":"35811_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1471-4159.2006.03731.x","volume":"97","author":"KJ Ahn","year":"2006","unstructured":"Ahn, K. J., Paik, S. R., Chung, K. C. & Kim, J. Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J Neurochem 97, 265\u2013279 (2006).","journal-title":"J Neurochem"},{"key":"35811_CR35","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","volume":"32","author":"M Usenovic","year":"2012","unstructured":"Usenovic, M., Tresse, E., Mazzulli, J. R., Taylor, J. P. & Krainc, D. Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity. J Neurosci 32, 4240\u20134246 (2012).","journal-title":"J Neurosci"},{"key":"35811_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2045-3701-1-10","volume":"1","author":"PM Chen","year":"2011","unstructured":"Chen, P. M., Gombart, Z. J. & Chen, J. W. Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration. Cell Biosci 1, 10 (2011).","journal-title":"Cell Biosci"},{"key":"35811_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbadis.2008.10.002","volume":"1782","author":"NB Nedelsky","year":"2008","unstructured":"Nedelsky, N. B., Todd, P. K. & Taylor, J. P. Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim Biophys Acta 1782, 691\u2013699 (2008).","journal-title":"Biochim Biophys Acta"},{"key":"35811_CR38","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G. & Anandatheerthavarada, H. K. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283, 9089\u20139100 (2008).","journal-title":"J Biol Chem"},{"key":"35811_CR39","doi-asserted-by":"publisher","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","volume":"289","author":"ES Luth","year":"2014","unstructured":"Luth, E. S., Stavrovskaya, I. G., Bartels, T., Kristal, B. S. & Selkoe, D. J. Soluble, prefibrillar alpha-synuclein oligomers promote complex I-dependent, Ca2+ -induced mitochondrial dysfunction. J Biol Chem 289, 21490\u201321507 (2014).","journal-title":"J Biol Chem"},{"key":"35811_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neulet.2009.02.056","volume":"454","author":"G Liu","year":"2009","unstructured":"Liu, G. et al. alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci Lett 454, 187\u2013192 (2009).","journal-title":"Neurosci Lett"},{"key":"35811_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","volume":"486","author":"SJ Chinta","year":"2010","unstructured":"Chinta, S. J., Mallajosyula, J. K., Rane, A. & Andersen, J. K. Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 486, 235\u2013239 (2010).","journal-title":"Neurosci Lett"},{"key":"35811_CR42","doi-asserted-by":"crossref","first-page":"342ra378","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio, R. et al. Alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease. Sci Transl Med 8, 342ra378 (2016).","journal-title":"Sci Transl Med"},{"key":"35811_CR43","doi-asserted-by":"publisher","first-page":"10263","DOI":"10.1074\/jbc.M115.695825","volume":"291","author":"J Demers-Lamarche","year":"2016","unstructured":"Demers-Lamarche, J. et al. Loss of Mitochondrial Function Impairs Lysosomes. J Biol Chem 291, 10263\u201310276 (2016).","journal-title":"J Biol Chem"},{"key":"35811_CR44","doi-asserted-by":"crossref","unstructured":"Saffari, A., Kolker, S., Hoffmann, G. F. & Ebrahimi-Fakhari, D. Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases. J Inherit Metab Dis (2017).","DOI":"10.1007\/s10545-017-0048-0"},{"key":"35811_CR45","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","volume":"134","author":"N Bengoa-Vergniory","year":"2017","unstructured":"Bengoa-Vergniory, N., Roberts, R. F., Wade-Martins, R. & Alegre-Abarrategui, J. Alpha-synuclein oligomers: a new hope. Acta Neuropathol 134, 819\u2013838 (2017).","journal-title":"Acta Neuropathol"},{"key":"35811_CR46","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.1713129115","volume":"115","author":"I Prots","year":"2018","unstructured":"Prots, I. et al. alpha-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci USA 115, 7813\u20137818 (2018).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35811_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/15548627.2017.1395992","volume":"14","author":"G Minakaki","year":"2018","unstructured":"Minakaki, G. et al. Autophagy inhibition promotes SNCA\/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy 14, 98\u2013119 (2018).","journal-title":"Autophagy"},{"key":"35811_CR48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2174\/1389450115666140225104705","volume":"15","author":"E Emanuele","year":"2014","unstructured":"Emanuele, E. Can trehalose prevent neurodegeneration? Insights from experimental studies. Curr Drug Targets 15, 551\u2013557 (2014).","journal-title":"Curr Drug Targets"},{"key":"35811_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.redox.2016.12.032","volume":"11","author":"M Redmann","year":"2017","unstructured":"Redmann, M., Wani, W. Y., Volpicelli-Daley, L., Darley-Usmar, V. & Zhang, J. Trehalose does not improve neuronal survival on exposure to alpha-synuclein pre-formed fibrils. Redox Biol 11, 429\u2013437 (2017).","journal-title":"Redox Biol"},{"key":"35811_CR50","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s12035-015-9173-7","volume":"53","author":"Q He","year":"2016","unstructured":"He, Q. et al. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV alpha-Synuclein Rat Model of Parkinson\u2019s Disease. Mol Neurobiol 53, 2258\u20132268 (2016).","journal-title":"Mol Neurobiol"},{"key":"35811_CR51","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1073\/pnas.60.3.1007","volume":"60","author":"B Sacktor","year":"1968","unstructured":"Sacktor, B. Trehalase and the transport of glucose in the mammalian kidney and intestine. Proc Natl Acad Sci USA 60, 1007\u20131014 (1968).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35811_CR52","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0278-6915(02)00011-X","volume":"40","author":"AB Richards","year":"2002","unstructured":"Richards, A. B. et al. Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol 40, 871\u2013898 (2002).","journal-title":"Food Chem Toxicol"},{"key":"35811_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nbd.2005.02.003","volume":"20","author":"R Liu","year":"2005","unstructured":"Liu, R., Barkhordarian, H., Emadi, S., Park, C. B. & Sierks, M. R. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42. Neurobiol Dis 20, 74\u201381 (2005).","journal-title":"Neurobiol Dis"},{"key":"35811_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13024-015-0004-0","volume":"10","author":"W Xiang","year":"2015","unstructured":"Xiang, W. et al. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity. Mol Neurodegener 10, 8 (2015).","journal-title":"Mol Neurodegener"},{"key":"35811_CR55","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nprot.2006.37","volume":"1","author":"G Tiscornia","year":"2006","unstructured":"Tiscornia, G., Singer, O. & Verma, I. M. Production and purification of lentiviral vectors. Nat Protoc 1, 241\u2013245 (2006).","journal-title":"Nat Protoc"},{"key":"35811_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep42942","volume":"7","author":"S Menges","year":"2017","unstructured":"Menges, S. et al. Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress. Sci Rep 7, 42942 (2017).","journal-title":"Sci Rep"},{"key":"35811_CR57","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 9, 676\u2013682 (2012).","journal-title":"Nat Methods"},{"key":"35811_CR58","doi-asserted-by":"publisher","first-page":"770","DOI":"10.4161\/auto.6458","volume":"4","author":"RK Dagda","year":"2008","unstructured":"Dagda, R. K., Zhu, J., Kulich, S. M. & Chu, C. T. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson\u2019s disease. Autophagy 4, 770\u2013782 (2008).","journal-title":"Autophagy"},{"key":"35811_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-1-61779-328-8_21","volume":"793","author":"J Zhu","year":"2011","unstructured":"Zhu, J., Dagda, R. K. & Chu, C. T. Monitoring mitophagy in neuronal cell cultures. Methods Mol Biol 793, 325\u2013339 (2011).","journal-title":"Methods Mol Biol"},{"key":"35811_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep14211","volume":"5","author":"A Sasaki","year":"2015","unstructured":"Sasaki, A., Arawaka, S., Sato, H. & Kato, T. Sensitive western blotting for detection of endogenous Ser129-phosphorylated alpha-synuclein in intracellular and extracellular spaces. Sci Rep 5, 14211 (2015).","journal-title":"Sci Rep"},{"key":"35811_CR61","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nprot.2006.62","volume":"1","author":"I Wittig","year":"2006","unstructured":"Wittig, I., Braun, H. P. & Schagger, H. Blue native PAGE. Nat Protoc 1, 418\u2013428 (2006).","journal-title":"Nat Protoc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35811-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35811-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:06:58Z","timestamp":1671253618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35811-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["35811"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35811-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"544"}}